Literature DB >> 22349906

[Beyond immunopathogenesis. Insulin resistance and "epidermal dysfunction"].

W-H Boehncke1, S Boehncke, C Buerger.   

Abstract

Insulin is a central player in the regulation of metabolic as well as non-metabolic cells: inefficient signal transduction (insulin resistance) not only represents the cornerstone in the pathogenesis of type 2 diabetes mellitus, but also drives atherosclerosis through inducing endothelial dysfunction. Last but not least epidermal homeostasis depends on insulin. We summarize the effects of insulin on proliferation and differentiation of human keratinocytes as well as the relevance of cytokine-induced insulin resistance for alterations in epidermal homeostasis characteristic for psoriasis. Kinases involved in both insulin- as well as cytokine-receptor signaling represent potential targets for innovative therapeutics. Such small molecules would primarily normalize "epidermal dysfunction", thus complementing the immunomodulatory strategies of today's biologics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349906     DOI: 10.1007/s00105-011-2227-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  14 in total

1.  Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes.

Authors:  E Wertheimer; M Trebicz; T Eldar; M Gartsbein; S Nofeh-Moses; T Tennenbaum
Journal:  J Invest Dermatol       Date:  2000-07       Impact factor: 8.551

2.  Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial.

Authors:  Sandra Boehncke; Stephan Fichtlscherer; Rebekka Salgo; Jurate Garbaraviciene; Heike Beschmann; Sandra Diehl; Katja Hardt; Diamant Thaçi; Wolf-Henning Boehncke
Journal:  Arch Dermatol Res       Date:  2010-12-18       Impact factor: 3.017

Review 3.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 4.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

5.  The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.

Authors:  Wolf-Henning Boehncke; Sandra Boehncke; Anne-Marie Tobin; Brian Kirby
Journal:  Exp Dermatol       Date:  2011-04       Impact factor: 3.960

6.  Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.

Authors:  R W Groves; T Rauschmayr; K Nakamura; S Sarkar; I R Williams; T S Kupper
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.

Authors:  H J Bovenschen; M M B Seyger; P C M Van de Kerkhof
Journal:  Br J Dermatol       Date:  2005-07       Impact factor: 9.302

8.  Akt1 controls insulin-driven VEGF biosynthesis from keratinocytes: implications for normal and diabetes-impaired skin repair in mice.

Authors:  Itamar Goren; Elke Müller; Dana Schiefelbein; Paul Gutwein; Oliver Seitz; Josef Pfeilschifter; Stefan Frank
Journal:  J Invest Dermatol       Date:  2008-07-31       Impact factor: 8.551

9.  Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.

Authors:  Guolian Li; Eugene J Barrett; Matthew O Barrett; Wenhong Cao; Zhenqi Liu
Journal:  Endocrinology       Date:  2007-04-19       Impact factor: 4.736

10.  Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells.

Authors:  Hope D I Anderson; Dolkun Rahmutula; David G Gardner
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.